Comparison of Abiraterone and Combined Androgen Blockade Therapy for High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Propensity Score-Matched Analysis

Overview of attention for article published in Frontiers in oncology, December 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 17,593 followers.

@AshleyGWinter This? "Comparison of Abiraterone and Combined Androgen Blockade Therapy for High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Propensity Score-Matched Analysis - PubMed" https://t.co/KYINXgrij9

14 Mar 2022

Reply Repost Favourite

📄 New article: Comparison of Abiraterone and Combined Androgen Blockade Therapy for High-Risk Metastatic Hormone-Sensitive #ProstateCancer: A Propensity Score-Matched Analysis 👨‍⚕️👩‍⚕️ Naoki Matsumura, Kazutoshi Fujita et al. Read 👉 https://t.co/b3D7BHlF

30 Dec 2021

Reply Repost Favourite

RT @FrontOncology: New research: Comparison of Abiraterone and Combined Androgen Blockade Therapy for High-Risk Metastatic Hormone-Sensitiv…

21 Dec 2021

Reply Repost Favourite

New research: Comparison of Abiraterone and Combined Androgen Blockade Therapy for High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Propensity Score-Matched Analysis: This study aimed to compare the effects of abiraterone acetate plus… https://t.c

21 Dec 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.